Research Articles

Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1

In an earlier study, we found that individuals with patent infection had significantly higher IgG antibody titers to the 19-kD C-terminal region of Plasmodium vivax merozoite surface protein 1 (PvMSP1) than individuals treated for malaria 1-4 months earlier. These results suggested that the antibody levels decreased rapidly following treatment. The present study was designed to determine the persistence of antibody response to the N- and C-terminal regions of PvMSP1 after infection with P. vivax in individuals from the city of Belem in northern Brazil. Our results demonstrated that the vast majority of individuals had a significant decrease in antibody titers to the C-terminal region of PvMSP1 in a period of two months following treatment. Among responders to the C-terminal region, 44.4% became serologically negative and 44.4% had their antibody titers reduced by an average of 13-fold. Only 11.2% of the individuals had their antibody titers maintained or slightly increased during that period. A decrease in the antibody response to the recombinant protein representing the N-terminal region of PvMSP1 was also noted; however, it was not as dramatic. The rapid decrease in the antibody levels to the C-terminal region of PvMSP1 might contribute to the high risk of reinfection in these individuals.

This article has been cited by other articles:

				J. L. Cole-Tobian, P. Michon, M. Biasor, J. S. Richards, J. G. Beeson, I. Mueller, and C. L. King Strain-Specific Duffy Binding Protein Antibodies Correlate with Protection against Infection with Homologous Compared to Heterologous Plasmodium vivax Strains in Papua New Guinean Children Infect. Immun., September 1, 2009; 77(9): 4009 - 4017. [Abstract] [Full Text] [PDF]

				D. R. Krause, M. L. Gatton, S. Frankland, D. P. Eisen, M. F. Good, L. Tilley, and Q. Cheng Characterization of the Antibody Response against Plasmodium falciparum Erythrocyte Membrane Protein 1 in Human Volunteers Infect. Immun., December 1, 2007; 75(12): 5967 - 5973. [Abstract] [Full Text] [PDF]

				T. M. TRAN, J. OLIVEIRA-FERREIRA, A. MORENO, F. SANTOS, S. S. YAZDANI, C. E. CHITNIS, J. D. ALTMAN, E. V-S. MEYER, J. W. BARNWELL, and M. R. GALINSKI COMPARISON OF IgG REACTIVITIES TO PLASMODIUM VIVAX MEROZOITE INVASION ANTIGENS IN A BRAZILIAN AMAZON POPULATION Am J Trop Med Hyg, August 1, 2005; 73(2): 244 - 255. [Abstract] [Full Text] [PDF]

				I. P. CERAVOLO, O. BRUNA-ROMERO, E. M. BRAGA, C. J. F. FONTES, C. F. A. BRITO, J. M. SOUZA, A. U. KRETTLI, J. H. ADAMS, and L. H. CARVALHO ANTI-PLASMODIUM VIVAX DUFFY BINDING PROTEIN ANTIBODIES MEASURE EXPOSURE TO MALARIA IN THE BRAZILIAN AMAZON Am J Trop Med Hyg, June 1, 2005; 72(6): 675 - 681. [Abstract] [Full Text] [PDF]

				J.-W. Park, S.-H. Moon, J.-S. Yeom, K.-J. Lim, M.-J. Sohn, W.-C. Jung, Y.-J. Cho, K.-W. Jeon, W. Ju, C.-S. Ki, et al. Naturally Acquired Antibody Responses to the C-Terminal Region of Merozoite Surface Protein 1 of Plasmodium vivax in Korea Clin. Vaccine Immunol., January 1, 2001; 8(1): 14 - 20. [Abstract] [Full Text] [PDF]

				L. A. Da Silveira, M. L. Dorta, E. A. S. Kimura, A. M. Katzin, F. Kawamoto, K. Tanabe, and M. U. Ferreira Allelic Diversity and Antibody Recognition of Plasmodium falciparum Merozoite Surface Protein 1 during Hypoendemic Malaria Transmission in the Brazilian Amazon Region Infect. Immun., November 1, 1999; 67(11): 5906 - 5916. [Abstract] [Full Text] [PDF]